Rejected at 6:04 p.m. Jul, 25, 2025 ] by Ahmed7
Author: andrewmathias8
Related Note: 1539204159804 4
Rationale for change

This card needs to be updated with the latest GINA 2023 protocol (see amboss). PRN SABA should no longer be used and formoterol+ICS (symbicort) is now the first line treatment. The way that I have constructed this card is messy, and I expect it to be rejected, but I hope that it can be used by someone else (one of the maintainers) as a template for an updated card.
Source: AMBOSS - https://next.amboss.com/us/article/Ph0WVf?utm_source=navbar&utm_medium=anki&utm_campaign=anki&utm_term=treatment%2Bof%2Basthma&guid=pLGVmv%252Cnl_&aid=298bfc66-b119-4c76-b7ef-8bfc7d192ab2&uid=ptfeLeLy0#Z052a35f9754e48907061f8bfd26e8fd3

Rejection reason

This card has been updated to reflect the NAEPP guidelines

Text Text
Extra Extra
One by one One by one
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
Empty field
OME
Empty field
Additional Resources
#AK_Step2_v12::!Shelf::EM #AK_Step2_v12::#Subjects::Pulmonology::05_Lungs::Obstructive_Lung_Disease::Asthma::Management_Redo #AK_Step2_v12::#Resources_by_rotation::FM::casefiles::wheezing&asthma #AK_Step2_v12::#CMS::IM::Form_05 #AK_Step2_v12::#NBME::Free120 #AK_Step2_v12::#AMBOSS::BxazA5 #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::04_Albuterol_vs_Salmeterol #AK_Other::Only_Step_2 #AK_Step2_v12::!FLAG_THESE_CARDS::Potential_duplicates #AK_Step2_v12::#NBME::Form09 #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step2_v12::#Bootcamp::Medicine::02_Pulmonary_and_Critical_Care::01_Obstructive_Lung_Diseases::02_Acute_Asthma_Management #AK_Other::AnKing_Image::Mujeeb::Asthma #PANCE::EOR::Family_med #AK_Step2_v12::Original_decks::Dorian::peds::emma #AK_Step2_v12::#Subjects::Pulmonology::05_Lungs::Obstructive_Lung_Disease::Asthma #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step1_v12::#AMBOSS::BxazA5 #PANCE::EOR::PEDS #AK_Step2_v12::Original_decks::Dorian::im::emma #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::06_Asthma_Treatment #AK_Step2_v12::#CMS::FM::Form_05 #AK_Step2_v12::#NBME::Form16::Section_2 #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::02_Chronic_Asthma_Management #AK_Step2_v12::#UWorld::Step::4617 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#Resources_by_rotation::IM::emma #AK_Other::Table::Asthma_Treatment #PANCE::EOR::IM #AK_Step2_v12::#CMS::IM::Form_08 #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::02_Allergy_&_Pulmonary::02_Asthma_therapy #AK_Step1_v12::#UWorld::Step::169 #AK_Step2_v12::Original_decks::Dorian::fam::casefiles::wheezing&asthma #AK_Step2_v12::#Resources_by_rotation::Peds::emma #AK_Step2_v12::#FirstAid::14_Pulm::01_Obstructive_Lung_Disease::02_Asthma #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::05_Treatment_of_COPD_and_Asthma #AK_Other::AnKing_Image::!Subjects::Pulmonology::Asthma_management #AK_Step2_v12::#UWorld::Step::23103 #AK_Step2_v12::#UWorld::COMLEX::101400 #AK_Step1_v12::#OME_banner #AK_Step2_v12::#SketchyPeds::05_Respiratory_&_Pulmonology::02_Lower_Airway_Disease::03_Asthma_in_Children #AK_Step1_v12::#UWorld::COMLEX::23282 #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::05_Fluticasone_&_Budesonide #AK_Step2_v12::#Bootcamp::Medicine::02_Pulmonary_and_Critical_Care::01_Obstructive_Lung_Diseases::04_Chronic_Asthma_Management #AK_Step2_v12::!Shelf::#Cards_AnKing_Skipped #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::02_Asthma #AK_Step1_v12::#AMBOSS::Ynan7O #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::06_Montelukast_&_Zafirlukast #AK_Step2_v12::#AMBOSS::z60rnS